Nephrotoxicity of rapamycin: an emerging problem in clinical medicine.
Marti
Hans-Peter
HP
Frey
Felix J
FJ
D017326:Clinical Trials, Phase III as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use / Q000633:toxicity*; D007668:Kidney / Q000187:drug effects*; D016030:Kidney Transplantation / Q000009:adverse effects / Q000379:methods; D008297:Male; D020714:Maximum Tolerated Dose; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D020123:Sirolimus / Q000627:therapeutic use / Q000633:toxicity*; D014181:Transplantation Immunology
D007166:Immunosuppressive Agents; D020123:Sirolimus